Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
160 hedge funds and large institutions have $2.42B invested in Intercept Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 56 reducing their positions, and 39 closing their positions.
4% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 56
7% less funds holding
Funds holding: 172 → 160 (-12)
13% less capital invested
Capital invested by funds: $2.77B → $2.42B (-$354M)
28% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 39
53% less call options, than puts
Call options by funds: $76.9M | Put options by funds: $163M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
+$41M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$38.5M |
| 3 |
PC
PointState Capital
New York
|
+$18.3M |
| 4 |
Millennium Management
New York
|
+$14.8M |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$40.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$37.1M |
| 3 |
Credit Agricole
Montrouge Cedex,
France
|
-$30.3M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$13.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.8M |
ICPT Hedge Fund Activity: Q1 2016 in Review
160 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q1 2016, worth a combined $2.42B — down 13% from $2.77B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of ICPT and 28 opened new positions — a net loss of 11 holders — while 56 trimmed existing stakes and 54 added.
The largest buyer was Carmignac Gestion, adding an estimated $41M. The largest seller was First Trust Advisors, cutting an estimated $40.1M.
- 160 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q1 2016, down from 172 in Q4 2015.
- Funds reported $2.42B of Intercept Pharmaceuticals, Inc. stock for Q1 2016, down 13% quarter-over-quarter.
- 28 funds opened new Intercept Pharmaceuticals, Inc. positions in Q1 2016 and 39 closed out, a net change of -11 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q1 2016 was Carmignac Gestion, an estimated $41M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q1 2016 was First Trust Advisors, an estimated $40.1M sold.
Based on aggregated 13F filings for Q1 2016.